Booz Allen Hamilton delivered a decisive earnings beat for its fiscal second quarter, reporting $1.76 per share against a $1.44 consensus and a $1.54 Earnings Whisper number. That is a 14.3% surprise and 18.1% year-over-year earnings growth. The top line did not keep pace. Revenue of $2.778 billion missed the $2.80 billion consensus by 0.8% and fell 3.9% from a year ago. Management also raised its fiscal 2027 adjusted EPS guidance to $6.50-$6.70, up from the $6.00-$6.35 range set last spring and reaffirmed in the first quarter. That is the central tension of the quarter. Earnings power is improving faster than expected, but the revenue base is still shrinking, and the newly closed Ultra IMC acquisition is now doing some of the work of holding the full-year revenue outlook together.

The quality of the beat deserves scrutiny. The press release itself was only a brief results announcement, so the detail came from the conference call. Part of the EPS raise rests on non-operating items: a CVC venture gain, a $10 million DARPA earn-out and a lower tax rate. Operating profitability looks steadier than spectacular. Adjusted EBITDA margin was 11.3%, up just 10 basis points year over year, a sharp slowdown from the 130-basis-point expansion and 11.9% margin in the first quarter. Management also guided to a further second-half margin step-down, citing lower civil volumes, investment timing and seasonality. The EBITDA and free cash flow guidance raises were modest and limited to the low end of each range: EBITDA now $1.26-$1.29 billion and free cash flow $850-$925 million.

Beneath the headline revenue decline, the trajectory is improving. Revenue excluding billable expenses fell less than 1% year over year, versus a 3.8% decline in the first quarter and roughly 7% in the fourth quarter of fiscal 2026. The national security business is the engine:

• It grew 6% excluding billables, though only 1% on a reported basis.
• Its qualified pipeline is up more than 20%.
• Its funded backlog is up about 10%.
• It added more than 300 employees as hiring reaccelerated.
• Its fixed-price mix rose three points year to date as outcome-based contracting gains traction.

Bookings were also strong. Book-to-bill was 1.5x for a second straight quarter, helped by a large classified award, after readings of 0.9x and 0.3x in the two quarters before. Total backlog climbed to about $41 billion from $38 billion two quarters ago.

Civil remains the drag, and it got worse on paper. Q2 civil revenue fell 15%, a modest improvement from -16% in Q1 and -23% in Q4. Even so, management cut the full-year civil outlook to a low-double-digit decline from high single digits, as procurements and recompetes keep slipping to the right. The full-year revenue range was narrowed to $11.3-$11.6 billion with the midpoint held, but only because Ultra offsets the civil reduction. That implies a softer organic outlook than the unchanged midpoint suggests. Other cracks are worth watching:

• Funded backlog growth slowed to 5% from 15% in the first quarter.
• Days sales outstanding rose to 82.
• Leverage increased after the $729 million Ultra purchase.
• A continuing resolution and the midterm elections cloud second-half funding.

The forward catalysts are real, however. Ultra brings double-digit growth and EBITDA margins above 20%, along with C3BM, edge compute, encryption and autonomy products. The Gail counter-superintelligence cyber product is in private beta and cut attack success rates by more than 95% in testing. Management's tone was notably more emphatic. It set a goal of expanding margins for the foreseeable future and returning to above-market, mid-single-digit growth. These are management aspirations, not results, and the guided second-half margin dip sits awkwardly beside the margin-expansion message.

The market setup is more constructive than investor sentiment suggests. Shares closed at $78.57 the day before the report, up 12.3% from the $69.99 open after the July release. That left the stock 2.1% above its 200-day moving average and 19.3% above its July 30 low of $65.88, though still 3.2% below the September 15 high of $81.19. Earnings Whispers sentiment improved only slightly, from -0.31 to -0.29, so investors remain skeptical despite the price recovery. Most of the internal trend readings are neutral, with only the AVWAP reading positive, consistent with a stock that has stabilized rather than broken out.

The bottom line is that Booz Allen delivered a convincing earnings beat and a meaningful EPS guidance raise, backed by genuine national security momentum, record backlog and a margin-accretive acquisition. But bears have legitimate ammunition. Revenue still declined and missed, civil was cut again, margin expansion stalled, funded backlog growth decelerated, and part of the EPS raise is non-operating. Investors should judge the quarter less by the headline surprise and more by whether national security growth can outrun the civil erosion once Ultra's contribution is set aside.